Govt exploring modalities of emergency authorisation of COVID-19 vaccine

New Delhi, November 22

The government is exploring the modalities of emergency authorisation and usage of anti-coronavirus vaccines pending completion of phase-three clinical trial and regular licensure.

The issue of advance purchase commitment for vaccines, including pricing, was also discussed in a recent meeting attended by NITI Aayog Member (Health) Vinod Paul, Principal Scientific Adviser to the government K Vijay Raghavan and Union Health Secretary Rajesh Bhushan.

“It was decided that the PMO-constituted Vaccine Task Force (VTF) will lay down the principles for emergency use authorisation while the National Expert Group On Vaccine Administration for COVID-19 (NEGVAC) should take the lead in setting the principles for advance market commitment, including vaccine pricing,” a source said.

These developments assume significance against the backdrop of Pfizer seeking emergency use authorisation of its COVID-19 vaccine from the US regulators. Another US-based biotechnology giant, Moderna, said it also intends to apply for an emergency use authorisation (EUA) with the US Food and Drug Administration (USFDA) in the coming weeks.

Meanwhile, five vaccines are under different phases of clinical trials in India. The Serum Institute of India is conducting the phase-three trial of the Oxford-AstraZeneca COVID-19 vaccine, while Bharat Biotech and ICMR has already started the phase-three trial of the indigenously developed COVAXIN jab.

An indigenously developed vaccine by Zydus Cadila has completed phase-two clinical trial in the country. Dr Reddy’s Laboratories will soon start combined phase two and three trials of the Russian COVID-19 vaccine Sputnik V in India.

According to the source, an urgent meeting of the vaccine task force (VTF) with experts will be convened to review the scientific status of vaccines globally and whether, if so how and when should the decision on emergency authorisation of vaccines be taken.

The terms of references for two major bodies dealing with vaccine introduction—the National Technical Advisory Group on Immunisation (NTAGI) and the Central Drug Standards and Control Organisation (CDSCO) — will be set and their roles clearly defined for authorisation and emergency authorisation.

It was also agreed at the meeting that one point of contact will be responsible for examining and responding to authorisations given (or in the pipeline), globally, the source said.

Towards advance market commitment, NEGVAC should lay down principles for procurement and price negotiations. Using these principles, negotiations should be speedily initiated.

It was also decided at the meeting that a NEGVAC group should be proactively reaching out to each company as their results from phase three are announced, a source said.

Pfizer and its German partner BioNTech have announced that its vaccine appears 95 per cent effective at preventing mild to severe COVID-19 disease in a large, ongoing study. Moderna has also announced that its COVID-19 vaccine has shown to be 94.5 per cent effective in preventing the deadly disease. — PTI

 



Disclaimer: This post has not been edited by our staff and is published from a syndicated feed. The Original Source of this post can be found at Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest

Coronavirus | Tripura imposes night curfew; ₹1,000 fine for social distancing violation

Tripura government on Wednesday imposed night curfew, from 10 p.m. to 5 a.m. till April 30, and enforced several...

LSGIs to spearhead COVID-19 management in Kerala

Chief Minister Pinarayi Vijayan said ward-level committees of local self-government institutions (LSGIs) comprising elected members, ASHA worker, Health Department staff, the police, and volunteers...

All-time high of 22,414 fresh cases

Kerala’s new augmented mass testing strategy, to test as many people as possible and to remove all COVID-19 infectious persons from the community to...

Bombing in hotel parking lot kills at least 4 in SW...

It was unclear who was behind the bombing at Serena Hotel. A powerful bomb exploded in the parking area of a luxury hotel in...

Daily special express from Puri to Gunupur

A daily special express train will be run between Puri and Gunupur with effect from April 22. The 08417 Puri-Gunupur special express will leave...

More Articles